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Ross procedure with a quadricuspid pulmonary autograft
Sebastian-Patrick Sommer, MD, Christoph Bara, MD, Theo Kofidis, MD, Axel Haverich, MD, PhD,
and Uwe Klima, MD, PhD, Hannover, Germany
Aortic valve replacement using the pulmonary autograftas described by Ross1 in 1967 is an excellent perma-nent therapy for aortic valve disease, particularly inyoung patients. This procedure facilitates the omis-
sion of anticoagulation. The pulmonary autograft displays a supe-
rior longevity and excellent hemodynamic properties in combina-
tion with a low incidence of thromboembolism compared with all
other aortic valve replacement procedures. However, its success is
dictated by the suitability of the pulmonary autograft before the
switch to the aortic position; a normal pulmonary valve (PV)
without anatomic abnormalities is a prerequisite for the achieve-
ment of a satisfying operative and hemodynamic result.
We report on the postoperative outcome and midterm fol-
low-up (4 years) of a 48-year-old female patient who underwent an
aortic valve replacement with a quadricuspid pulmonary autograft.
A quadricuspid PV is a rare anatomic feature with an incidence of
1 in 1100 individuals.2 To our knowledge, the use of a quadricus-
pid autograft in the Ross procedure has not been reported before.3
Clinical Summary
A 48-year-old female patient presented with signs of congestive
heart failure such as peripheral edema and fatigue. Cardiac aus-
cultation revealed a typical systolic murmur with punctum maxi-
mum in the third right intercostal space and projection into the
carotid arteries. Angiography and echocardiography revealed good
left ventricular function (left ventricular ejection fraction 60%) and
severe left ventricular hypertrophy caused by advanced valvular
stenosis with a calculated orifice area (aortic valve area) of 0.45
cm2 and increased transvalvular gradient of 121/84 mm Hg (peak/
mean). The ascending aorta showed poststenotic dilation with a
maximal diameter of 40 mm. The aortic root was normal with a
diameter of 25 mm.
The patient underwent aortic autograft valve replacement. Prepa-
ration of the pulmonary and aortic valve was performed in a standard
technique during cardiac arrest on extracorporeal circulation. After the
pulmonary autograft was excised, a quadricuspid morphology became
evident (PV), which was undetected before surgery. Vigorous irriga-
tion tests demonstrated a patent PV without any sign of regurgitation.
The autograft was implanted in a free-root replacement technique.
The postoperative course was uneventful, and the patient was dis-
charged on postoperative day 12 in excellent condition. Echocardi-
ography performed intraoperatively and transthoracic echocardiogra-
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Figure 1. Transthoracic echocardiography of the quadricuspid
autograft 4 years after Ross procedure. The quadricuspid valve is
superimposed by lines to demonstrate the margins of the 4 leaf-
lets.
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phy performed 1 month after surgery demonstrated a morphologically
and functionally normal autograft.
Four years later, a routine follow-up echocardiography was
performed in the clinically asymptomatic patient and revealed
good left ventricular function with an ejection fraction of 65%.
Although no recurrence of aortic stenosis was detectable, a second-
degree aortic regurgitation (Figure 1) was evident in color Doppler
echocardiography. The patient denied any symptoms, despite her
physically demanding profession.
Discussion
Donald Ross1 introduced the use of the pulmonary autograft for aortic
valve replacement in 1967. This technique allows the replacement of
a diseased aortic valve with the autologous PV. Thus, systemic
anticoagulation is circumvented, and the risk of thromboembolism or
cerebral bleeding is negligible. In comparison with all other valve
substitutes, the free-root technique shows the best hemodynamic
outcome and consequently is the most frequently used approach.4
However, the normally tricuspid PV must be of regular anatomy and
function. To our knowledge the use of a quadricuspid pulmonary
autograft has not been described before. The early postoperative result
with the quadricuspid autograft was promising. However, the devel-
opment of autograft regurgitation of second degree (echocardio-
graphic guidelines) as early as 4 years after surgical treatment iden-
tifies quadricuspid autografts as potentially problematic for this
procedure. Preoperative echocardiographic evaluation of PV function
and morphology are therefore mandatory.
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Aortic root replacement in a patient with pulmonary dysfunction caused
by severe chest deformity associated with Marfan syndrome
Iki Adachi, MD,a Hitoshi Ogino, MD,a Hideaki Imanaka, MD,b Hitoshi Matsuda, MD,a Kenji Minatoya, MD,a
and Hiroaki Sasaki, MD,a Osaka, Japan
Great advances in respiratory management have re-cently widened the indication for cardiovascular sur-gery for patients with pulmonary dysfunction. Wedescribe a patient with an extremely low vital capacity
caused by severe chest deformity who tolerated aortic root replace-
ment as a result of adequate respiratory management, including
bilevel positive airway pressure (BiPAP) ventilation.
Clinical Summary
A 39-year-old man with Marfan syndrome was scheduled to un-
dergo aortic root replacement for annuloaortic ectasia and aortic
insufficiency. He had been receiving home oxygen therapy for 10
years and nocturnal use of nasal continuous positive airway pres-
sure ventilation for 1 year because of frequent episodes of respi-
ratory failure.
On admission, he showed respiratory distress at grade IV of the
Hugh-Jones classification. Spirometry showed a severe restrictive
pattern: vital capacity of 1080 mL (28% of predicted value) and
forced expiratory volume in 1 second of 890 mL. Arterial blood
gases (ABGs) under 1 L of oxygen inhalation revealed metaboli-
cally compensated hypercapnia: pH, 7.41; PaCO2, 60.8 mm Hg;
PaO2, 80.4 mm Hg; base excess, 10.9 mmol/L. Chest radiography
showed cardiomegaly with mild lung congestion and severe sco-
liosis (Figure 1). Computed tomographic (CT) scans revealed the
dilated aortic root (62 mm in diameter) and marked elongation of
the descending aorta along the vertebral bodies (Figure 2). Trans-
thoracic echocardiography revealed a redundant tricuspid aortic
valve with severe regurgitation. The left ventricular ejection frac-
tion was 45%, as estimated by ventriculography.
At the time of sternotomy, we paid particular attention to
avoiding lung injury and to not opening the pleural spaces. After
establishment of cardiopulmonary bypass, the aortic root was
replaced with a composite graft by use of the Carrel patch tech-
nique because aortic leaflets were severely degenerated. Weaning
from bypass was uneventful.
ABGs on admission to the intensive care unit were favorable:
pH, 7.38; PaCO2, 50.1 mm Hg; PaO2, 167.2 mm Hg; base excess,
4.4 mmol/L (synchronized intermittent mandatory ventilation;
fraction of inspired oxygen of 0.5; respiratory rate of 12 breaths/
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